IL101885A - 3-(substituted amino)-5-alkyl-6-arylpyridazine derivatives their preparation and pharmaceutical compositions containing them - Google Patents

3-(substituted amino)-5-alkyl-6-arylpyridazine derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL101885A
IL101885A IL10188592A IL10188592A IL101885A IL 101885 A IL101885 A IL 101885A IL 10188592 A IL10188592 A IL 10188592A IL 10188592 A IL10188592 A IL 10188592A IL 101885 A IL101885 A IL 101885A
Authority
IL
Israel
Prior art keywords
group
formula
compound
azabicyclo
oct
Prior art date
Application number
IL10188592A
Other languages
English (en)
Other versions
IL101885A0 (en
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of IL101885A0 publication Critical patent/IL101885A0/xx
Publication of IL101885A publication Critical patent/IL101885A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL10188592A 1991-05-16 1992-05-15 3-(substituted amino)-5-alkyl-6-arylpyridazine derivatives their preparation and pharmaceutical compositions containing them IL101885A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105973A FR2676444B1 (fr) 1991-05-16 1991-05-16 Nouveaux derives d'amino-3 pyridazines actifs sur le systeme nerveux central, procede de preparation et compositions pharmaceutiques en contenant.

Publications (2)

Publication Number Publication Date
IL101885A0 IL101885A0 (en) 1992-12-30
IL101885A true IL101885A (en) 1996-08-04

Family

ID=9412856

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10188592A IL101885A (en) 1991-05-16 1992-05-15 3-(substituted amino)-5-alkyl-6-arylpyridazine derivatives their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US5276036A (de)
EP (1) EP0514277B1 (de)
JP (1) JPH0673021A (de)
KR (1) KR920021517A (de)
AT (1) ATE115569T1 (de)
AU (1) AU656770B2 (de)
BR (1) BR9201854A (de)
CA (1) CA2068770A1 (de)
CZ (1) CZ282531B6 (de)
DE (1) DE69200895T2 (de)
DK (1) DK0514277T3 (de)
ES (1) ES2065755T3 (de)
FI (1) FI922235A7 (de)
FR (1) FR2676444B1 (de)
GR (1) GR3015389T3 (de)
HU (2) HUT61305A (de)
IE (1) IE66926B1 (de)
IL (1) IL101885A (de)
MX (1) MX9202282A (de)
NO (1) NO180233C (de)
NZ (1) NZ242760A (de)
RU (1) RU2088577C1 (de)
TW (1) TW227997B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631255A (en) * 1989-02-07 1997-05-20 Sanofi Pyridazine derivatives
US5461053A (en) * 1989-02-07 1995-10-24 Sanofi Pyridazine derivatives
JP2983141B2 (ja) * 1993-10-06 1999-11-29 株式会社三和化学研究所 新規化合物及び該化合物を有効成分とする脳機能改善剤
GB9707693D0 (en) * 1997-04-16 1997-06-04 Smithkline Beecham Plc Novel method of treatment
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
EP1526134B1 (de) * 2000-05-26 2008-09-03 Pfizer Limited Triazolyltropanderivate als ccr5-modulatoren
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
US8265724B2 (en) * 2007-03-09 2012-09-11 Nellcor Puritan Bennett Llc Cancellation of light shunting
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
MX2020001425A (es) 2017-08-04 2020-08-06 Skyhawk Therapeutics Inc Metodos y composiciones para modular el empalme.
CA3090130A1 (en) * 2018-02-02 2019-08-08 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
KR102913697B1 (ko) 2019-02-05 2026-01-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
EP3920918A4 (de) * 2019-02-05 2022-11-16 Skyhawk Therapeutics, Inc. Verfahren und zusammensetzungen zur modulierung von spleissung
WO2020163406A1 (en) * 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
WO2020163541A1 (en) * 2019-02-05 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7603594B2 (ja) * 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
KR102925385B1 (ko) 2019-02-06 2026-02-11 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
AR119731A1 (es) 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
US11129829B2 (en) 2019-06-17 2021-09-28 Skyhawk Therapeutics, Inc. Methods for modulating splicing
EP4289823A4 (de) * 2021-02-08 2025-02-26 Medshine Discovery Inc. Substituierte pyridazinphenolderivate
UY40374A (es) 2022-08-03 2024-02-15 Novartis Ag Inhibidores de inflamasoma nlrp3

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2539741A1 (fr) * 1983-01-21 1984-07-27 Sanofi Sa Composes a noyau heterocyclique diazote, leur procede de preparation et les medicaments, actifs sur le systeme nerveux central, qui en contiennent
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
PT93060B (pt) * 1989-02-07 1995-12-29 Sanofi Sa Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
FR2665442B1 (fr) * 1990-07-31 1992-12-04 Sanofi Sa Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2663326B2 (fr) * 1989-11-17 1992-10-16 Sanofi Sa Derives de la pyridazine, procede de preparation et compositions pharmaceutiques en contenant.
FR2642648B1 (fr) * 1989-02-07 1991-06-21 Sanofi Sa Utilisation de derives d'alkyl-5 pyridazine comme medicaments actifs sur le systeme cholinergique
GB8911158D0 (en) * 1989-05-16 1989-07-05 Janssen Pharmaceutica Nv Antiviral pyridazinamines

Also Published As

Publication number Publication date
MX9202282A (es) 1992-12-01
FI922235L (fi) 1992-11-17
DE69200895T2 (de) 1995-06-29
IE921557A1 (en) 1992-11-18
IL101885A0 (en) 1992-12-30
HUT61305A (en) 1992-12-28
NO180233C (no) 1997-03-12
GR3015389T3 (en) 1995-06-30
US5276036A (en) 1994-01-04
AU1627492A (en) 1992-11-19
NO180233B (no) 1996-12-02
EP0514277B1 (de) 1994-12-14
CZ282531B6 (cs) 1997-08-13
RU2088577C1 (ru) 1997-08-27
FI922235A7 (fi) 1992-11-17
BR9201854A (pt) 1993-01-05
NZ242760A (en) 1994-12-22
NO921949D0 (no) 1992-05-15
JPH0673021A (ja) 1994-03-15
CA2068770A1 (en) 1992-11-17
DE69200895D1 (de) 1995-01-26
TW227997B (de) 1994-08-11
NO921949L (no) 1992-11-17
IE66926B1 (en) 1996-02-07
HU9201626D0 (en) 1992-08-28
EP0514277A1 (de) 1992-11-19
CZ147392A3 (en) 1993-03-17
KR920021517A (ko) 1992-12-18
DK0514277T3 (da) 1995-05-01
ES2065755T3 (es) 1995-02-16
AU656770B2 (en) 1995-02-16
HU211920A9 (en) 1996-01-29
ATE115569T1 (de) 1994-12-15
FI922235A0 (fi) 1992-05-15
FR2676444A1 (fr) 1992-11-20
FR2676444B1 (fr) 1995-03-10

Similar Documents

Publication Publication Date Title
US5276036A (en) 3-(N-azabicycloalkyl)aminopyridazine derivatives and pharmaceutical compositions in which they are present
US7173033B2 (en) Nitrogen-containing heterocyclic compound
US4755517A (en) Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
ES2353279T3 (es) Fenilaminopiridinas y su uso como inhibidores de la rho-quinasa.
EP0377967A2 (de) 9-Aza-3-(oxa/thia)-bicyclo(3,2,1)nonanderivate, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
JPH02108679A (ja) 1,3,4―チアジアゾール誘導体、その製法および医薬組成物
EP1562945A1 (de) 1,4-dizabicyclo(3,2,2)nonane derivative, verfahren zur ihre herstellung und therapeutical verwendung
JP2007520526A (ja) コリン作動性受容体モジュレーターとしてのジアザビシクロアリール誘導体
AU639043B2 (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
EP0309544A1 (de) Psychotropische bizyklische imide.
HU180540B (en) Process for producing new,5,11-dihydro-6h-pyrido-square bracket-2,3-b-square bracket closed-square bracket-1,4-square bracket closed-benzodiasepin-6-ones
HK1000597B (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
US5318977A (en) New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
EP0154142B1 (de) Substituierte Hexahydroarylchinolizine
PT97013A (pt) Processo para a preparacao de compostos azabiciclicos
US20040127491A1 (en) Novel diazabicyclic biaryl derivatives
NZ286340A (en) Amides of 2-(4-indolyl piperazia-1-yl)-1-ph-enyl (and bemzyl)ethyl amine derivatives with various (cyclo) alkane carboxylic acids; pharmaceutical compositions
CA1314885C (en) Tricyclic derivatives which are agonists of cholinergic receptors, and drugs in which they are present
US5516782A (en) New meso-azacyclic aromatic acid amides and esters as novel serotonergic agents
AU607354B2 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl) butyl bridged bicyclic imides
JPH04234369A (ja) 6−アルキルピリダジン誘導体、調製方法およびそれらを含有する医薬組成物
JPH05271230A (ja) ジアザビシクロ誘導体

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees